{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T01:43:12Z","timestamp":1790214192827,"version":"4.1.0"},"reference-count":60,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2017,11,24]],"date-time":"2017-11-24T00:00:00Z","timestamp":1511481600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2017,11,24]],"date-time":"2017-11-24T00:00:00Z","timestamp":1511481600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Squamous cell carcinomas of the head and neck (SCCHN) affect anatomical sites including the oral cavity, nasal cavity, pharynx, and larynx. Laryngeal cancers are characterized by high recurrence and poor overall survival, and currently lack robust molecular prognostic biomarkers for treatment stratification. Using an algorithm for integrative clustering that simultaneously assesses gene expression, somatic mutation, copy number variation, and methylation, we for the first time identify laryngeal cancer subtypes with distinct prognostic outcomes, and differing from the non-prognostic laryngeal subclasses reported by The Cancer Genome Atlas (TCGA). Although most common laryngeal gene mutations are found in both subclasses, better prognosis is strongly associated with damaging mutations of the methyltransferases<jats:italic>NSD1<\/jats:italic>and<jats:italic>NSD2<\/jats:italic>, with findings confirmed in an independent validation cohort consisting of 63 laryngeal cancer patients. Intriguingly, NSD1\/2 mutations are not prognostic for nonlaryngeal SCCHN. These results provide an immediately useful clinical metric for patient stratification and prognostication.<\/jats:p>","DOI":"10.1038\/s41467-017-01877-7","type":"journal-article","created":{"date-parts":[[2017,11,20]],"date-time":"2017-11-20T17:27:30Z","timestamp":1511198850000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":50,"title":["NSD1- and NSD2-damaging mutations define a subset of laryngeal tumors with favorable prognosis"],"prefix":"10.1038","volume":"8","author":[{"given":"Suraj","family":"Peri","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Evgeny","family":"Izumchenko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7316-2727","authenticated-orcid":false,"given":"Adrian D.","family":"Schubert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael J.","family":"Slifker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karen","family":"Ruth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ilya G.","family":"Serebriiskii","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Theresa","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara A.","family":"Burtness","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ranee","family":"Mehra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric A.","family":"Ross","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Sidransky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3618-3673","authenticated-orcid":false,"given":"Erica A.","family":"Golemis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,11,24]]},"reference":[{"key":"1877_CR1","doi-asserted-by":"publisher","first-page":"870","DOI":"10.1158\/1078-0432.CCR-14-2481","volume":"21","author":"MK Keck","year":"2015","unstructured":"Keck, M. K. et al. Integrative analysis of head and neck cancer identifies two biologically distinct HPV and three non-HPV subtypes. Clin. Cancer Res.: Off. J. Am. Assoc. Cancer Res. 21, 870\u2013881 (2015).","journal-title":"Clin. Cancer Res.: Off. J. Am. Assoc. Cancer Res."},{"key":"1877_CR2","doi-asserted-by":"publisher","first-page":"1779","DOI":"10.1158\/1078-0432.CCR-08-1463","volume":"15","author":"JP Klussmann","year":"2009","unstructured":"Klussmann, J. P. et al. Genetic signatures of HPV-related and unrelated oropharyngeal carcinoma and their prognostic implications. Clin. Cancer Res.: Off. J.Am. Assoc. Cancer Res. 15, 1779\u20131786 (2009).","journal-title":"Clin. Cancer Res.: Off. J.Am. Assoc. Cancer Res."},{"key":"1877_CR3","doi-asserted-by":"publisher","first-page":"1154","DOI":"10.1126\/science.1206923","volume":"333","author":"N Agrawal","year":"2011","unstructured":"Agrawal, N. et al. Exome sequencing of head and neck squamous cell carcinoma reveals inactivating mutations in NOTCH1. Science 333, 1154\u20131157 (2011).","journal-title":"Science"},{"key":"1877_CR4","doi-asserted-by":"publisher","first-page":"1157","DOI":"10.1126\/science.1208130","volume":"333","author":"N Stransky","year":"2011","unstructured":"Stransky, N. et al. The mutational landscape of head and neck squamous cell carcinoma. Science 333, 1157\u20131160 (2011).","journal-title":"Science"},{"key":"1877_CR5","doi-asserted-by":"publisher","first-page":"5444","DOI":"10.1158\/1078-0432.CCR-12-3280","volume":"19","author":"RA Lleras","year":"2013","unstructured":"Lleras, R. A. et al. Unique DNA methylation loci distinguish anatomic site and HPV status in head and neck squamous cell carcinoma. Clin. Cancer Res.: Off. J. Am. Assoc. Cancer Res. 19, 5444\u20135455 (2013).","journal-title":"Clin. Cancer Res.: Off. J. Am. Assoc. Cancer Res."},{"key":"1877_CR6","doi-asserted-by":"publisher","first-page":"1031","DOI":"10.4161\/epi.29025","volume":"9","author":"R Guerrero-Preston","year":"2014","unstructured":"Guerrero-Preston, R. et al. Key tumor suppressor genes inactivated by \u201cgreater promoter\u201d methylation and somatic mutations in head and neck cancer. Epigenetics: Off. J. DNA Methyl. Soc. 9, 1031\u20131046 (2014).","journal-title":"Epigenetics: Off. J. DNA Methyl. Soc."},{"key":"1877_CR7","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1016\/S1535-6108(04)00112-6","volume":"5","author":"CH Chung","year":"2004","unstructured":"Chung, C. H. et al. Molecular classification of head and neck squamous cell carcinomas using patterns of gene expression. Cancer Cell 5, 489\u2013500 (2004).","journal-title":"Cancer Cell"},{"key":"1877_CR8","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1038\/nature14129","volume":"517","author":"Cancer Genome Atlas, N..","year":"2015","unstructured":"Cancer Genome Atlas, N.. Comprehensive genomic characterization of head and neck squamous cell carcinomas. Nature 517, 576\u2013582 (2015).","journal-title":"Nature"},{"key":"1877_CR9","doi-asserted-by":"publisher","first-page":"1410","DOI":"10.1093\/annonc\/mdu167","volume":"25","author":"A Argiris","year":"2014","unstructured":"Argiris, A. et al. Prognostic significance of human papillomavirus in recurrent or metastatic head and neck cancer: an analysis of eastern cooperative oncology Group trials. Ann. Oncol.: Off. J. Eur. Soc. Med. Oncol. 25, 1410\u20131416 (2014).","journal-title":"Ann. Oncol.: Off. J. Eur. Soc. Med. Oncol."},{"key":"1877_CR10","doi-asserted-by":"publisher","first-page":"e1001786","DOI":"10.1371\/journal.pmed.1001786","volume":"12","author":"EA Mroz","year":"2015","unstructured":"Mroz, E. A., Tward, A. D., Hammon, R. J., Ren, Y. & Rocco, J. W. Intra-tumor genetic heterogeneity and mortality in head and neck cancer: analysis of data from the cancer genome atlas. PLoS Med. 12, e1001786 (2015).","journal-title":"PLoS Med."},{"key":"1877_CR11","doi-asserted-by":"publisher","first-page":"4245","DOI":"10.1073\/pnas.1208949110","volume":"110","author":"Q Mo","year":"2013","unstructured":"Mo, Q. et al. Pattern discovery and cancer gene identification in integrated cancer genomic data. Proc. Natl Acad. Sci. USA 110, 4245\u20134250 (2013).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1877_CR12","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1038\/ng.3051","volume":"46","author":"AM Gross","year":"2014","unstructured":"Gross, A. M. et al. Multi-tiered genomic analysis of head and neck cancer ties TP53 mutation to 3p loss. Nat. Genet. 46, 939\u2013943 (2014).","journal-title":"Nat. Genet."},{"key":"1877_CR13","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1038\/nature19057","volume":"536","author":"M Lek","year":"2016","unstructured":"Lek, M. et al. Analysis of protein-coding genetic variation in 60,706 humans. Nature 536, 285\u2013291 (2016).","journal-title":"Nature"},{"key":"1877_CR14","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1038\/ncb1722","volume":"10","author":"PA Gregory","year":"2008","unstructured":"Gregory, P. A. et al. The miR-200 family and miR-205 regulate epithelial to mesenchymal transition by targeting ZEB1 and SIP1. Nat. Cell. Biol. 10, 593\u2013601 (2008).","journal-title":"Nat. Cell. Biol."},{"key":"1877_CR15","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1158\/1078-0432.CCR-12-1558","volume":"19","author":"LA Byers","year":"2013","unstructured":"Byers, L. A. et al. An epithelial-mesenchymal transition gene signature predicts resistance to EGFR and PI3K inhibitors and identifies Axl as a therapeutic target for overcoming EGFR inhibitor resistance. Clin. Cancer Res.: Off. J. Am. Assoc. Cancer Res. 19, 279\u2013290 (2013).","journal-title":"Clin. Cancer Res.: Off. J. Am. Assoc. Cancer Res."},{"key":"1877_CR16","doi-asserted-by":"publisher","first-page":"15545","DOI":"10.1073\/pnas.0506580102","volume":"102","author":"A Subramanian","year":"2005","unstructured":"Subramanian, A. et al. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc. Natl Acad. Sci. USA 102, 15545\u201315550 (2005).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1877_CR17","doi-asserted-by":"publisher","DOI":"10.1186\/s13059-014-0550-8","volume":"15","author":"MI Love","year":"2014","unstructured":"Love, M. I., Huber, W. & Anders, S. Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biol. 15, 550 (2014).","journal-title":"Genome Biol."},{"key":"1877_CR18","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1038\/ng863","volume":"30","author":"N Kurotaki","year":"2002","unstructured":"Kurotaki, N. et al. Haploinsufficiency of NSD1 causes Sotos syndrome. Nat. Genet. 30, 365\u2013366 (2002).","journal-title":"Nat. Genet."},{"key":"1877_CR19","first-page":"158","volume":"1816","author":"M Morishita","year":"2011","unstructured":"Morishita, M. & di Luccio, E. Cancers and the NSD family of histone lysine methyltransferases. Biochim. Biophys. Acta 1816, 158\u2013163 (2011).","journal-title":"Biochim. Biophys. Acta"},{"key":"1877_CR20","doi-asserted-by":"publisher","first-page":"1386","DOI":"10.1038\/ng.2777","volume":"45","author":"JD Jaffe","year":"2013","unstructured":"Jaffe, J. D. et al. Global chromatin profiling reveals NSD2 mutations in pediatric acute lymphoblastic leukemia. Nat. Genet. 45, 1386\u20131391 (2013).","journal-title":"Nat. Genet."},{"key":"1877_CR21","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1073\/pnas.0912493107","volume":"107","author":"T Lu","year":"2010","unstructured":"Lu, T. et al. Regulation of NF-kappaB by NSD1\/FBXL11-dependent reversible lysine methylation of p65. Proc. Natl Acad. Sci. USA 107, 46\u201351 (2010).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1877_CR22","doi-asserted-by":"publisher","DOI":"10.1038\/cddis.2014.569","volume":"6","author":"H Nakshatri","year":"2015","unstructured":"Nakshatri, H. et al. NF-kappaB-dependent and -independent epigenetic modulation using the novel anti-cancer agent DMAPT. Cell Death Dis. 6, e1608 (2015).","journal-title":"Cell Death Dis."},{"key":"1877_CR23","doi-asserted-by":"publisher","first-page":"1105","DOI":"10.1093\/nar\/gkv1038","volume":"44","author":"ST Lee","year":"2016","unstructured":"Lee, S. T. & Wiemels, J. L. Genome-wide CpG island methylation and intergenic demethylation propensities vary among different tumor sites. Nucleic Acids Res. 44, 1105\u20131117 (2016).","journal-title":"Nucleic Acids Res."},{"key":"1877_CR24","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms10207","volume":"6","author":"S Choufani","year":"2015","unstructured":"Choufani, S. et al. NSD1 mutations generate a genome-wide DNA methylation signature. Nat. Commun. 6, 10207 (2015).","journal-title":"Nat. Commun."},{"key":"1877_CR25","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1038\/nature14176","volume":"520","author":"T Baubec","year":"2015","unstructured":"Baubec, T. et al. Genomic profiling of DNA methyltransferases reveals a role for DNMT3B in genic methylation. Nature 520, 243\u2013247 (2015).","journal-title":"Nature"},{"key":"1877_CR26","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1038\/nrg2540","volume":"10","author":"H Cedar","year":"2009","unstructured":"Cedar, H. & Bergman, Y. Linking DNA methylation and histone modification: patterns and paradigms. Nat. Rev. Genet. 10, 295\u2013304 (2009).","journal-title":"Nat. Rev. Genet."},{"key":"1877_CR27","doi-asserted-by":"publisher","first-page":"19489","DOI":"10.1074\/jbc.M513249200","volume":"281","author":"H Li","year":"2006","unstructured":"Li, H. et al. The histone methyltransferase SETDB1 and the DNA methyltransferase DNMT3A interact directly and localize to promoters silenced in cancer cells. J. Biol. Chem. 281, 19489\u201319500 (2006).","journal-title":"J. Biol. Chem."},{"key":"1877_CR28","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1038\/nature21373","volume":"543","author":"F Neri","year":"2017","unstructured":"Neri, F. et al. Intragenic DNA methylation prevents spurious transcription initiation. Nature 543, 72\u201377 (2017).","journal-title":"Nature"},{"key":"1877_CR29","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1038\/ng.3757","volume":"49","author":"S Papillon-Cavanagh","year":"2017","unstructured":"Papillon-Cavanagh, S. et al. Impaired H3K36 methylation defines a subset of head and neck squamous cell carcinomas. Nat. Genet. 49, 180\u2013185 (2017).","journal-title":"Nat. Genet."},{"key":"1877_CR30","doi-asserted-by":"publisher","first-page":"21830","DOI":"10.1073\/pnas.0906831106","volume":"106","author":"M Berdasco","year":"2009","unstructured":"Berdasco, M. et al. Epigenetic inactivation of the Sotos overgrowth syndrome gene histone methyltransferase NSD1 in human neuroblastoma and glioma. Proc. Natl Acad. Sci. USA 106, 21830\u201321835 (2009).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1877_CR31","doi-asserted-by":"publisher","first-page":"804","DOI":"10.1038\/ncb1608","volume":"9","author":"GG Wang","year":"2007","unstructured":"Wang, G. G., Cai, L., Pasillas, M. P. & Kamps, M. P. NUP98-NSD1 links H3K36 methylation to Hox-A gene activation and leukaemogenesis. Nat. Cell. Biol. 9, 804\u2013812 (2007).","journal-title":"Nat. Cell. Biol."},{"key":"1877_CR32","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1111\/j.1469-7580.2012.01540.x","volume":"222","author":"V Soukup","year":"2013","unstructured":"Soukup, V., Horacek, I. & Cerny, R. Development and evolution of the vertebrate primary mouth. J. Anat. 222, 79\u201399 (2013).","journal-title":"J. Anat."},{"key":"1877_CR33","doi-asserted-by":"publisher","unstructured":"Sato, T., Issa, J. J. & Kropf, P. DNA Hypomethylating drugs in cancer therapy. Cold Spring Harbor Perspect. Med. 7, doi:10.1101\/cshperspect.a026948 (2017).","DOI":"10.1101\/cshperspect.a026948"},{"key":"1877_CR34","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1038\/nm.4036","volume":"22","author":"KH Kim","year":"2016","unstructured":"Kim, K. H. & Roberts, C. W. Targeting EZH2 in cancer. Nat. Med. 22, 128\u2013134 (2016).","journal-title":"Nat. Med."},{"key":"1877_CR35","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1097\/CCO.0000000000000390","volume":"29","author":"M Yamagishi","year":"2017","unstructured":"Yamagishi, M. & Uchimaru, K. Targeting EZH2 in cancer therapy. Curr. Opin. Oncol. 29, 375\u2013381 (2017).","journal-title":"Curr. Opin. Oncol."},{"key":"1877_CR36","doi-asserted-by":"publisher","first-page":"e1004566","DOI":"10.1371\/journal.pgen.1004566","volume":"10","author":"R Popovic","year":"2014","unstructured":"Popovic, R. et al. Histone methyltransferase MMSET\/NSD2 alters EZH2 binding and reprograms the myeloma epigenome through global and focal changes in H3K36 and H3K27 methylation. PLoS Genet. 10, e1004566 (2014).","journal-title":"PLoS Genet."},{"key":"1877_CR37","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1101\/gad.2017311","volume":"25","author":"L Chin","year":"2011","unstructured":"Chin, L., Hahn, W. C., Getz, G. & Meyerson, M. Making sense of cancer genomic data. Genes Dev. 25, 534\u2013555 (2011).","journal-title":"Genes Dev."},{"key":"1877_CR38","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1093\/bib\/bbq004","volume":"12","author":"MA van de Wiel","year":"2011","unstructured":"van de Wiel, M. A., Picard, F., van Wieringen, W. N. & Ylstra, B. Preprocessing and downstream analysis of microarray DNA copy number profiles. Brief Bioinform. 12, 10\u201321 (2011).","journal-title":"Brief Bioinform."},{"key":"1877_CR39","doi-asserted-by":"publisher","first-page":"e118","DOI":"10.1093\/nar\/gkr407","volume":"39","author":"B Reva","year":"2011","unstructured":"Reva, B., Antipin, Y. & Sander, C. Predicting the functional impact of protein mutations: application to cancer genomics. Nucleic Acids Res. 39, e118 (2011).","journal-title":"Nucleic Acids Res."},{"key":"1877_CR40","doi-asserted-by":"publisher","first-page":"pl1","DOI":"10.1126\/scisignal.2004088","volume":"6","author":"J Gao","year":"2013","unstructured":"Gao, J. et al. Integrative analysis of complex cancer genomics and clinical profiles using the cBioPortal. Sci. Signal. 6, pl1 (2013).","journal-title":"Sci. Signal."},{"key":"1877_CR41","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1186\/1471-2105-11-587","volume":"11","author":"P Du","year":"2010","unstructured":"Du, P. et al. Comparison of Beta-value and M-value methods for quantifying methylation levels by microarray analysis. BMC Bioinf. 11, 587 (2010).","journal-title":"BMC Bioinf."},{"key":"1877_CR42","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1158\/1541-7786.MCR-13-0614","volume":"12","author":"SV Laddha","year":"2014","unstructured":"Laddha, S. V., Ganesan, S., Chan, C. S. & White, E. Mutational landscape of the essential autophagy gene BECN1 in human cancers. Mol. Cancer Res. 12, 485\u2013490 (2014).","journal-title":"Mol. Cancer Res."},{"key":"1877_CR43","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2164-14-293","volume":"14","author":"R Pidsley","year":"2013","unstructured":"Pidsley, R. et al. A data-driven approach to preprocessing Illumina 450\u2009K methylation array data. BMC Genomics 14, 293 (2013).","journal-title":"BMC Genomics"},{"key":"1877_CR44","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1111\/j.2517-6161.1995.tb02031.x","volume":"57","author":"Y Benjamini","year":"1995","unstructured":"Benjamini, Y. & Hochhberg, Y. Controlling the false discovery rate: a practical and powerful approach to multiple testing. J. R. Stat. Soc. B 57, 289\u2013300 (1995).","journal-title":"J. R. Stat. Soc. B"},{"key":"1877_CR45","doi-asserted-by":"publisher","DOI":"10.1186\/gb-2014-15-2-r29","volume":"15","author":"CW Law","year":"2014","unstructured":"Law, C. W., Chen, Y., Shi, W. & Smyth, G. K. voom: precision weights unlock linear model analysis tools for RNA-seq read counts. Genome Biol. 15, R29 (2014).","journal-title":"Genome Biol."},{"key":"1877_CR46","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1038\/nature08460","volume":"462","author":"DA Barbie","year":"2009","unstructured":"Barbie, D. A. et al. Systematic RNA interference reveals that oncogenic KRAS-driven cancers require TBK1. Nature 462, 108\u2013112 (2009).","journal-title":"Nature"},{"key":"1877_CR47","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1038\/nprot.2008.211","volume":"4","author":"W Huang da","year":"2009","unstructured":"Huang da, W., Sherman, B. T. & Lempicki, R. A. Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat. Protoc. 4, 44\u201357 (2009).","journal-title":"Nat. Protoc."},{"key":"1877_CR48","doi-asserted-by":"publisher","first-page":"884","DOI":"10.1038\/nmeth.3088","volume":"11","author":"M Streit","year":"2014","unstructured":"Streit, M. et al. Guided visual exploration of genomic stratifications in cancer. Nat. Methods 11, 884\u2013885 (2014).","journal-title":"Nat. Methods"},{"key":"1877_CR49","doi-asserted-by":"publisher","first-page":"6569","DOI":"10.1200\/JCO.2005.07.009","volume":"23","author":"MO Hoque","year":"2005","unstructured":"Hoque, M. O. et al. Quantitative methylation-specific polymerase chain reaction gene patterns in urine sediment distinguish prostate cancer patients from control subjects. J. Clin. Oncol.: Off. J. Am. Soc. Clin. Oncol. 23, 6569\u20136575 (2005).","journal-title":"J. Clin. Oncol.: Off. J. Am. Soc. Clin. Oncol."},{"key":"1877_CR50","doi-asserted-by":"publisher","first-page":"1754","DOI":"10.1093\/bioinformatics\/btp324","volume":"25","author":"H Li","year":"2009","unstructured":"Li, H. & Durbin, R. Fast and accurate short read alignment with Burrows-Wheeler transform. Bioinformatics 25, 1754\u20131760 (2009).","journal-title":"Bioinformatics"},{"key":"1877_CR51","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1038\/ng.806","volume":"43","author":"MA DePristo","year":"2011","unstructured":"DePristo, M. A. et al. A framework for variation discovery and genotyping using next-generation DNA sequencing data. Nat. Genet. 43, 491\u2013498 (2011).","journal-title":"Nat. Genet."},{"key":"1877_CR52","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1038\/nbt.2514","volume":"31","author":"K Cibulskis","year":"2013","unstructured":"Cibulskis, K. et al. Sensitive detection of somatic point mutations in impure and heterogeneous cancer samples. Nat. Biotechnol. 31, 213\u2013219 (2013).","journal-title":"Nat. Biotechnol."},{"key":"1877_CR53","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.jmoldx.2013.09.003","volume":"16","author":"DH Spencer","year":"2014","unstructured":"Spencer, D. H. et al. Performance of common analysis methods for detecting low-frequency single nucleotide variants in targeted next-generation sequence data. J. Mol. Diagnos. 16, 75\u201388 (2014).","journal-title":"J. Mol. Diagnos."},{"key":"1877_CR54","doi-asserted-by":"publisher","first-page":"e164","DOI":"10.1093\/nar\/gkq603","volume":"38","author":"K Wang","year":"2010","unstructured":"Wang, K., Li, M. & Hakonarson, H. ANNOVAR: functional annotation of genetic variants from high-throughput sequencing data. Nucleic Acids Res. 38, e164 (2010).","journal-title":"Nucleic Acids Res."},{"key":"1877_CR55","doi-asserted-by":"publisher","first-page":"2283","DOI":"10.1093\/bioinformatics\/btp373","volume":"25","author":"DC Koboldt","year":"2009","unstructured":"Koboldt, D. C. et al. VarScan: variant detection in massively parallel sequencing of individual and pooled samples. Bioinformatics 25, 2283\u20132285 (2009).","journal-title":"Bioinformatics"},{"key":"1877_CR56","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/nprot.2015.123","volume":"11","author":"R Vaser","year":"2016","unstructured":"Vaser, R., Adusumalli, S., Leng, S. N., Sikic, M. & Ng, P. C. SIFT missense predictions for genomes. Nat. Protoc. 11, 1\u20139 (2016).","journal-title":"Nat. Protoc."},{"key":"1877_CR57","doi-asserted-by":"publisher","unstructured":"Adzhubei, I., Jordan, D. M. & Sunyaev, S. R. Predicting functional effect of human missense mutations using PolyPhen-2. In Current protocols in human genetics\/editorial board(Jonathan L. Haines et al.) Chapter 7, Unit7 20, doi:10.1002\/0471142905.hg0720s76 (2013).","DOI":"10.1002\/0471142905.hg0720s76"},{"key":"1877_CR58","doi-asserted-by":"publisher","first-page":"1585","DOI":"10.1093\/oxfordjournals.molbev.a003945","volume":"18","author":"M Anisimova","year":"2001","unstructured":"Anisimova, M., Bielawski, J. P. & Yang, Z. Accuracy and power of the likelihood ratio test in detecting adaptive molecular evolution. Mol. Biol. Evol. 18, 1585\u20131592 (2001).","journal-title":"Mol. Biol. Evol."},{"key":"1877_CR59","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1002\/humu.22225","volume":"34","author":"HA Shihab","year":"2013","unstructured":"Shihab, H. A. et al. Predicting the functional, molecular, and phenotypic consequences of amino acid substitutions using hidden markov models. Hum. Mutat. 34, 57\u201365 (2013).","journal-title":"Hum. Mutat."},{"key":"1877_CR60","unstructured":"Therneau, T. M. & Grambsch, P. M. Modeling Survival Data: Extending the Cox Model (Springer-Verlag, 2010)."}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-017-01877-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-017-01877-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-017-01877-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,28]],"date-time":"2024-06-28T20:19:38Z","timestamp":1719605978000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-017-01877-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,11,24]]},"references-count":60,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2017,12]]}},"alternative-id":["1877"],"URL":"https:\/\/doi.org\/10.1038\/s41467-017-01877-7","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,11,24]]},"assertion":[{"value":"12 November 2015","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 October 2017","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 November 2017","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing financial interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1772"}}